TeselaGen In the News

vector editor old

TechCrunch: TeselaGen Is Building A Platform For Rapid Prototyping in Synthetic Biology

Using the power of nature in conjunction with advanced technology and informatics to produce and develop solutions for farmers is essential to advance agriculture. Today, TeselaGen Biotechnology Inc., and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), announced they have entered into a collaboration to produce a state-of-the-art biological design automation platform that can speed discovery work.

Read More »
Silicon Valley

TeselaGen wins Bio-IT World’s 2013 Best Practices Award

There are plenty of plaudits for organizations in the life sciences that change the industry’s conceptions of what is possible, but one purpose of the Bio-IT World Best Practices Awards is to highlight those who refine those achievements until the merely possible becomes truly practical. That is why Bio-IT World was pleased to award an honorable mention at the 2013 Best Practices Awards to TeselaGen Biotechnology, a startup that spun out from the Berkeley Lab’s Joint BioEnergy Institute (JBEI) in 2011, and Amgen for the development of TeselaGen: j5, an automated platform for designing DNA assembly protocols. This new, cloud-based platform allows even small institutions to quickly find the most cost-effective protocols for assembling scarless, multipart DNA.

Read More »
Clean air

TeselaGen To Accelerate Biotech Industry With J5

TeselaGen has secured an exclusive license in all fields of use for the “j5” gene assembly software from Lawrence Berkeley National Laboratory . TeselaGen prevailed with the strongest proposal to promote and leverage the j5 technology for their rapid prototyping system for synthetic biology. Based on the idea that a forward engineering approach needs to incorporate the utility of both biology and engineering in the quest for easier and faster ways to build biomolecules, TeselaGen is expecting the j5 technology to play an important role in its software as a service offering. The j5 software package, which has attracted users from more than 250 institutions worldwide since it was made available last year, emerged from the Joint BioEnergy Institute, a Department of Energy research center established in 2007 to pursue breakthroughs in the production of cellulosic biofuels. By building on j5 and adding modules for commercial users, TeselaGen Biotechnology, says it will significantly reduce the time and cost involved with DNA synthesis and cloning, a multibillion-dollar market.

Read More »

Subscribe

We're committed to your privacy. TeselaGen uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time.